MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Cash Flow Overview
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
Stock-based compensation and rel...
Proceeds from issuance of common...
Accounts payable and accrued lia...
Others
Negative Cash Flow Breakdown
Net loss
Proceeds from the exercise of wa...
Accrued compensation and benefit...
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2026-06-30
2025-09-30
2025-06-30
Loss on disposal of property and equipment
-
0
0
Net loss
-12,292
-2,868
-5,014
Depreciation
-3
1
2
Non-cash operating lease expense
-84
22
62
Recurring fair value measurements of liabilities
330
-332
9
Issuance of common stock to vendors
-
0
0
Write-off of deferred equity issuance costs
-75
0
75
Stock-based compensation and related charges
8,854
90
138
Other
-
61
-
Accounts receivable
500
-
-
Prepaid and other current assets and other noncurrent assets
378
519
18
Accounts payable and accrued liabilities
1,789
-955
1,210
Accrued compensation and benefits
-922
429
-530
Operating lease liabilities
90
-24
-66
Net cash used in operating activities
-3,790
-3,553
-4,150
Payments on insurance financing debt
-109
100
80
Proceeds from issuance of common stock
3,250
0
0
Proceeds from the exercise of warrants
-3,754
3,908
1
Shares withheld for payment of employee withholding tax liability
-
0
0
Payment of warrant inducement issuance costs
-
445
0
Payment of equity issuance costs
-104
0
178
Proceeds from issuance of common stock under employee stock purchase plan
17
0
3
Net cash provided by (used in) financing activities
171
3,363
-254
Net decrease in cash, cash equivalents and restricted cash
-3,619
-190
-4,404
Cash, cash equivalents and restricted cash, beginning of year
5,253
9,847
-
Cash, cash equivalents and restricted cash, end of period
125,227
-
-
Cash and cash equivalents
125,172
-
-
Restricted cash
55
-
-
Total cash, cash equivalents and restricted cash
125,227
5,253
-
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
Proceeds from issuance of
common stock
$3,250K
something is missing
$445K
Payments on insurance
financing debt
-$109K
(-236.25%↓ Y/Y)
Payment of equity
issuance costs
-$104K
(-158.43%↓ Y/Y)
Proceeds from issuance of
common stock under...
$17K
(466.67%↑ Y/Y)
Net cash provided by
(used in) financing...
$171K
(167.32%↑ Y/Y)
Canceled cashflow
$3,754K
Net decrease in
cash, cash...
-$3,619K
(17.82%↑ Y/Y)
Canceled cashflow
$171K
Stock-based compensation
and related charges
$8,854K
(6315.94%↑ Y/Y)
Accounts payable and
accrued liabilities
$1,789K
(47.85%↑ Y/Y)
Operating lease
liabilities
$90K
(236.36%↑ Y/Y)
Proceeds from the
exercise of warrants
-$3,754K
(-375500.00%↓ Y/Y)
Net cash used in
operating activities
-$3,790K
(8.67%↑ Y/Y)
Canceled cashflow
$10,733K
Net loss
-$12,292K
(-145.15%↓ Y/Y)
Accrued compensation
and benefits
-$922K
(-73.96%↓ Y/Y)
Accounts receivable
$500K
Prepaid and other
current assets and other...
$378K
(2000.00%↑ Y/Y)
Recurring fair value
measurements of liabilities
$330K
(3566.67%↑ Y/Y)
Non-cash operating lease
expense
-$84K
(-235.48%↓ Y/Y)
Write-off of deferred
equity issuance costs
-$75K
(-200.00%↓ Y/Y)
Buy us a coffee
PALISADE BIO, INC. (PALI)
PALISADE BIO, INC. (PALI)